T1	Premise 42 161	A 23-year-old male diagnosed with Wolff-Parkinson-White syndrome who comes to the emergency department for palpitations
T2	Premise 163 289	The ECG shows an irregular wide QRS tachycardia, with a heart rate of 205 bpm, compatible with pre-excited atrial fibrillation
T3	Claim 376 385	Verapamil
T4	Claim 390 397	Digoxin
T5	Claim 402 411	Adenosine
T6	Claim 416 428	Procainamide
T7	Claim 455 467	Procainamide
T8	Claim 469 564	The treatment of choice for Wolff-Parkinson-White syndrome is cardioversion with direct current
T9	Claim 566 645	Heart rate slowing drugs, commonly used in atrial fibrillation, are ineffective
T10	Claim 651 756	digoxin and non-dihydropyridine calcium channel blockers (e.g., verapamil, diltiazem) are contraindicated
T11	Treatment 651 658	digoxin
T12	Treatment 663 707	non-dihydropyridine calcium channel blockers
T13	Treatment 715 724	verapamil
T14	Treatment 726 735	diltiazem
T15	Claim 765 838	they may increase the ventricular rate and cause ventricular fibrillation
T16	Marker 757 764	because
R1	Attack Ent1:T10 Ent2:T4	
R2	Attack Ent1:T10 Ent2:T3	
T17	Claim 840 953	If cardioversion is not possible, drugs that prolong the refractory period of accessory connection should be used
T18	Claim 955 1058	IV procainamide or amiodarone is preferred, but any class Ia, Ic or III antiarrhythmic drug can be used
R3	Support Ent1:T7 Ent2:T6	
T19	Marker 999 1002	but
R4	Attack Ent1:T9 Ent2:T5	
R5	Support Ent1:T18 Ent2:T6	
T20	Treatment 955 970	IV procainamide
T21	Treatment 974 984	amiodarone
T22	Treatment 376 385	Verapamil
T23	Treatment 390 397	Digoxin
T24	Treatment 402 411	Adenosine
T25	Treatment 416 428	Procainamide
